Effect of nucleolin down-regulation on the proliferation and apoptosis in C2C12 cells

Journal of Central South University (Medical Sciences)

Volumn 30, Issue 2, 2005, Pages 125-129

  Wang, Kang Kai ^a   Jiang, Lei ^a   E, Shun Mei ^a   Liu, Ke ^a   Zhang, Ling Li ^a   Liu, Mei Dong ^a   Xiao, Xian Zhong ^a  

^a Central South University   (China)

Author keywords

Antisense oligonucleotides; Apoptosis; C2C 12 myogenic cells; Nucleolin; Proliferation

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTISENSE OLIGONUCLEOTIDE; NUCLEOLIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DETERMINATION; DOWN REGULATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; MICE; MYOBLASTS; MYOCYTES, CARDIAC; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHOPROTEINS; RNA-BINDING PROTEINS; TRANSFECTION;

EID: 20144378467     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Nicholson D W. From bench to clinic with apoptosis-based therapeutic agents[J]. Nature, 2000, 407(6805): 810-816.
2. Mehmet H. Apoptosis: Caspases find a new place to hide[J]. Nature, 2000, 403(6765): 29-30.
3. Ginisty H, Sicard H, Roger B, et al. Structure and functions of nucleolin[J]. J Cell Sci, 1999, 112 (Pt 6): 761-772.
4. Srovastava M, Pollard HB. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights[J]. FASEB J, 1999, 13(14): 1911-1922.
5. Mi Y, Thomas SD, Xu X, et al. Apoptosis in leukemia cells is accompanied by alterations in the levels and localization of nucleolin [J]. J Biol Chem, 2003, 278(10): 8572-8579.
6. Kito S, Shimizu K, Okamura H, et al. Cleavage of nucleolin and argyrophilic nucleolar organizer region associated proteins in apoptosis-induced cells[J]. Biochem Biophys Res Commun, 2003, 300 (4): 950-956.
7. Martelli AM, Zweyer M, Ochs RL, et al. Nuclear apoptotic changes: An overview[J]. J Cell Biochem, 2001, 82(4): 634-646.
8. Brocksted E, Rickers A, Kostka S, et al. Identification of apoptosis-associated protein in human Burkitt lymphoma cell line[J]. J Biol Chem, 1998, 273(43): 28057-28064.
9. Crooke ST. Progress in antisense technology[J]. Annu Rev Med, 2004, 55: 61-95. (Review)
10. Crooke ST. Antisense strategies[J]. Curr Mol Med, 2004, 4(5): 465-487.
11. Lin SL, Sukasweang S, Chuong CM, et al. D-RNAi (messenger RNA-antisense DNA interference) as a novel defense system against cancer and viral infections[J]. Curr Cancer Drug Targets, 2003, 3(3): 237.
12. Myers KJ, Dean NM. Sensible use of antisense: how to use oligonucleotides as research tools[J]. TIPS, 2000, 21(1): 19-23.
13. Pasternack MS, Bleier KJ, McInerney TN. Granzyme A binding to target cell proteins. Granzyme A binds to and cleaves nucleolin in vitro[J]. J Biol Chem, 1991, 266(22): 14703-14708.
14. Okada H, Mak TW. Pathways of apoptotic and non-apoptotic death in tumour cells[J]. Nat Rev Cancer, 2004, 4(8): 592-603.
15. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death[J]. Science, 2004, 305(5684): 626-629.